Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
1(11%)
Results Posted
83%(5 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_3
4
44%
Ph not_applicable
3
33%
Ph phase_2
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
4(50.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 34 (50.0%)
N/A3 (37.5%)

Trials by Status

terminated222%
completed667%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruiting

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

NCT05916469
terminatedphase_3

Cannabidiol and Management of Endometriosis Pain

NCT04527003
completednot_applicable

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

NCT05476172
terminatedphase_3

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

NCT03970330
completednot_applicable

Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

NCT02353247
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05916469

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Recruiting
NCT04527003Phase 3

Cannabidiol and Management of Endometriosis Pain

Terminated
NCT05476172Not Applicable

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

Completed
NCT03970330Phase 3

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

Terminated
NCT02353247Not Applicable

Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

Completed
NCT02542410Phase 2

Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study

Completed
NCT01667978Not Applicable

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Completed
NCT00003771Phase 3

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Completed
NCT01140217Phase 3

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9